WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010118474) COMPOUNDS AFFECTING GLYCEMIC INDEX
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/118474    International Application No.:    PCT/AU2010/000427
Publication Date: 21.10.2010 International Filing Date: 16.04.2010
IPC:
C07D 311/30 (2006.01), A61K 36/899 (2006.01), A61P 3/04 (2006.01), A61P 3/10 (2006.01), A61K 31/352 (2006.01), C07D 311/40 (2006.01)
Applicants: SACRON INNOVATIONS PTY LIMITED [AU/AU]; Level 1, 80 Jephson Street Toowong QLD 4066 (AU) (For All Designated States Except US).
PAYN, Dionne Nadine [GB/AU]; (AU) (For US Only).
LEACH, David Norman [AU/AU]; (AU) (For US Only).
DESEO, Myrna A. [PH/AU]; (AU) (For US Only).
MORRIS, Carol Ann [AU/US]; (US) (For US Only)
Inventors: PAYN, Dionne Nadine; (AU).
LEACH, David Norman; (AU).
DESEO, Myrna A.; (AU).
MORRIS, Carol Ann; (US)
Agent: FISHER ADAMS KELLY; Level 29 12 Creek Street Brisbane, Queensland 4000 (AU)
Priority Data:
2009901641 17.04.2009 AU
Title (EN) COMPOUNDS AFFECTING GLYCEMIC INDEX
(FR) COMPOSÉS AFFECTANT L'INDICE GLYCÉMIQUE
Abstract: front page image
(EN)Compounds of formula I are disclosed which are useful as glycemic index lowering agents and/or, as α-amylase and/or α-glucosidase inhibitors. Also disclosed are nutritional and/or pharmaceutical compositions and supplements comprising one or more of these compounds. The compounds will be beneficial to patients who require stabilization of their postprandial glucose levels.
(FR)L'invention porte sur des composés de formule I qui sont utiles comme agents d'abaissement d'indice glycémique et/ou comme inhibiteurs d'α-amylase et/ou d'α-glucosidase. L'invention porte également sur des compositions et compléments nutritionnels et/ou pharmaceutiques comprenant un ou plusieurs de ces composés. Les composés bénéficieront aux patients qui nécessitent une stabilisation de leurs glycémies post-prandiales.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)